# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011406
Filing Date
2021-05-14
Accepted
2021-05-14 09:05:29
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 691304
2 |  | ex31-1.htm | EX-31.1 | 11015
3 |  | ex31-2.htm | EX-31.2 | 11321
4 |  | ex32-1.htm | EX-32.1 | 8370
| Complete submission text file | 0001493152-21-011406.txt |  | 4141407

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | clsn-20210331.xml | EX-101.INS | 600638
6 | XBRL SCHEMA FILE | clsn-20210331.xsd | EX-101.SCH | 55901
7 | XBRL CALCULATION FILE | clsn-20210331_cal.xml | EX-101.CAL | 72287
8 | XBRL DEFINITION FILE | clsn-20210331_def.xml | EX-101.DEF | 213689
9 | XBRL LABEL FILE | clsn-20210331_lab.xml | EX-101.LAB | 403811
10 | XBRL PRESENTATION FILE | clsn-20210331_pre.xml | EX-101.PRE | 307508

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 21922158
SIC: 2834 Pharmaceutical Preparations